Your Complete Guide to Global Clinical Research and GCP Compliance
Coding, Case Narratives & Follow-Up in Practice: Step-by-Step Guide for Sponsors and CROs Coding, Case Narratives & Follow-Up in Practice: Step-by-Step Guide for Sponsors and CROs In the rapidly evolving landscape of clinical research, especially with the rise of virtual clinical trials companies, understanding the intricacies of coding, case narratives, and follow-up processes is paramount…
CTMS, eTMF & eISF: Digital Strategy Blueprint for Modern Clinical Trials CTMS, eTMF & eISF: Digital Strategy Blueprint for Modern Clinical Trials As the clinical trial landscape continues to evolve, the need for efficient and effective digital strategies becomes increasingly critical. This tutorial serves as a comprehensive guide for clinical operations, regulatory affairs, and medical…
Read More “CTMS, eTMF & eISF: Digital Strategy Blueprint for Modern Clinical Trials” »
How to Select and Implement CTMS, eTMF & eISF That Scales Across Studies How to Select and Implement CTMS, eTMF & eISF That Scales Across Studies In the rapidly evolving landscape of clinical research, it is imperative for clinical operations, regulatory affairs, and medical affairs professionals to select and implement clinical trial management systems (CTMS),…
Read More “How to Select and Implement CTMS, eTMF & eISF That Scales Across Studies” »
Data Quality and Reconciliation Controls for Robust SUSAR Detection & Expedited Reporting Data Quality and Reconciliation Controls for Robust SUSAR Detection & Expedited Reporting In the context of clinical trials, the identification, reporting, and management of Suspected Unexpected Serious Adverse Reactions (SUSARs) is critical for ensuring participant safety and regulatory compliance. This step-by-step tutorial guide…
Global Considerations for SUSAR Detection & Expedited Reporting Across US, EU and UK Programs Global Considerations for SUSAR Detection & Expedited Reporting Across US, EU and UK Programs In the arena of clinical trials, rigorous monitoring and reporting of adverse events are crucial for ensuring participant safety and maintaining regulatory compliance. Among these adverse events…
Future Trends: AI, Automation and Real-World Data in SUSAR Detection & Expedited Reporting In the evolving landscape of clinical trials, particularly regarding the complexities surrounding serious unexpected suspected adverse reactions (SUSARs), there is a growing emphasis on utilizing technologies like artificial intelligence (AI), automation, and real-world data (RWD) to enhance detection and expedite reporting processes….
Global Roll-Out Models for IRT/IWRS & Supply Management Across US, EU and UK Programs The clinical trial landscape is evolving rapidly, and with it, the need for efficient and robust systems for randomization and trial supply management has grown. Interactive Response Technology (IRT) and Interactive Web Response Systems (IWRS) are integral to this process. This…
Read More “Global Roll-Out Models for IRT/IWRS & Supply Management Across US, EU and UK Programs” »
Future Trends: AI, Cloud and Real-World Data in IRT/IWRS & Supply Management Future Trends: AI, Cloud and Real-World Data in IRT/IWRS & Supply Management Introduction: Embracing the Future of Clinical Trials As the clinical trials landscape evolves, integration of advanced technologies such as artificial intelligence (AI), cloud computing, and the utilization of real-world data (RWD)…
Read More “Future Trends: AI, Cloud and Real-World Data in IRT/IWRS & Supply Management” »
Integrating SUSAR Detection & Expedited Reporting With DSURs, PBRERs and Risk Management Plans Integrating SUSAR Detection & Expedited Reporting With DSURs, PBRERs and Risk Management Plans In the landscape of clinical trials, particularly those involving pharmaceuticals and biologics, the management of adverse events and reporting criteria has evolved significantly. As clinical operations, regulatory affairs, and…
Vendor and Partner Oversight Considerations in SUSAR Detection & Expedited Reporting Vendor and Partner Oversight Considerations in SUSAR Detection & Expedited Reporting Understanding the Regulatory Framework In the realm of clinical trials, particularly those related to alopecia areata clinical trials, robust regulatory frameworks govern the handling of adverse events, notably the identification and reporting of…
Read More “Vendor and Partner Oversight Considerations in SUSAR Detection & Expedited Reporting” »
Don’t leave empty-handed. Watch practical GMP scenarios, inspection lessons, deviations, CAPA thinking, and real compliance insights on our YouTube channel. One click now can save you hours later.